GHRP-1: what it is and what the evidence says
The first of the family of GH-releasing hexa- and heptapeptides that act on the ghrelin receptor.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
Hormones work in axes: a signal from the brain tells a gland to release another hormone, and so on down the chain, with brakes that shut the process off. Intervening at one point has consequences both upstream and downstream. That is why this is the group where professional assessment stops being a recommendation and becomes essential.
What it is studied for
Acute GH release.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
The evidence is scarce and old: one study in children and adolescents confirming that it acutely releases GH, plus anti-doping control work. There is no trial evaluating body composition, strength or performance.
The limitation that matters most
All that has been demonstrated is an acute GH spike, which is not the same as a benefit: there are no data on chronic administration or on long-term safety, and this family is not selective (it also raises cortisol and prolactin).
Regulatory status
Not approved. Banned in sport (WADA S2).
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Almost no modern literature. Banned in sport.
Any interest in pushing the GH axis calls first for an endocrine workup, since a genuine deficiency is diagnosed and treated along quite different lines.
What this page cannot give you
A reference page can take you this far. You know what GHRP-1 is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescentshuman Acta Endocrinol (Copenh) · 1993 · PMID 8279223 →
- Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelinhuman Drug Test Anal · 2015 · PMID 25869809 →
- Effects in vitro of new growth hormone releasing peptide (GHRP-1) on growth hormone secretion from ovine pituitary cells in primary culturepreclinical J Neuroendocrinol · 1994 · PMID 8049717 →
- Growth hormone-releasing peptidesreview Eur J Endocrinol · 1997 · PMID 9186261 →
- Growth hormone-releasing peptides and their analogsreview Front Neuroendocrinol · 1998 · PMID 9465289 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for GHRP-1 or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is GHRP-1?
The first of the family of GH-releasing hexa- and heptapeptides that act on the ghrelin receptor. It is studied within the area of hormonal/sexual.
Is there human evidence for GHRP-1?
The evidence is scarce and old: one study in children and adolescents confirming that it acutely releases GH, plus anti-doping control work. There is no trial evaluating body composition, strength or performance.
Is it approved by any health agency?
Not approved. Banned in sport (WADA S2).
What is the dose of GHRP-1?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what GHRP-1 is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.